ArticleTargeted oncology2022

Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.

Marco Maruzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.